BLFS Crosses Above Average Analyst Target
September 19, 2017 at 09:17 AM EDT
In recent trading, shares of Biolife Solutions Inc (BLFS) have crossed above the average analyst 12-month target price of $5.08, changing hands for $5.29/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..